Idioma:

The precursor of resolvin D series and aspirin‐triggered resolvin D1 display anti‐hyperalgesic properties in adjuvant‐induced arthritis in rats

Lima‐Garcia, JF ; Dutra, RC ; da Silva, KABS ; Motta, EM ; Campos, MM ; Calixto, JB

British journal of pharmacology, 2011-09, Vol.164 (2), p.278-293 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por

Enviar para

Título:
The precursor of resolvin D series and aspirin‐triggered resolvin D1 display anti‐hyperalgesic properties in adjuvant‐induced arthritis in rats
Autor: Lima‐Garcia, JF ; Dutra, RC ; da Silva, KABS ; Motta, EM ; Campos, MM ; Calixto, JB
Assuntos: 17(R)HDoHE ; Animals ; arthritis ; Arthritis - chemically induced ; Arthritis - complications ; AT‐RvD1 ; Biological and medical sciences ; Chronic Disease ; Diseases of the osteoarticular system ; Docosahexaenoic Acids - chemistry ; Docosahexaenoic Acids - therapeutic use ; Dose-Response Relationship, Drug ; Freund's Adjuvant - toxicity ; Hot Temperature ; Inflammation - chemically induced ; Inflammation - complications ; Inflammatory joint diseases ; inflammatory pain ; Male ; Medical sciences ; Miscellaneous. Osteoarticular involvement in other diseases ; Pain - drug therapy ; Pain - etiology ; Pharmacology. Drug treatments ; Rats ; Research Papers with Commentaries ; Rodents ; RvD series precursor
É parte de: British journal of pharmacology, 2011-09, Vol.164 (2), p.278-293
Descrição: BACKGROUND AND PURPOSE Resolution of inflammation is mediated by endogenous molecules with anti‐inflammatory and pro‐resolving activities and they have generated new possibilities for the treatment of inflammatory diseases. Here, we have investigated the possible anti‐hyperalgesic effects of two lipids, aspirin‐triggered resolvin D1 (AT‐RvD1) and its precursor, 17(R)‐hydroxy‐4Z,7Z,10Z,13Z,15E,17R,19Z‐docosahexaenoic acid (17(R)HDoHE). EXPERIMENTAL APPROACH The anti‐hyperalgesic effects of both lipid mediators were evaluated, using mechanical and thermal stimuli, at different time‐points in adjuvant‐induced arthritis in rats. Cytokine levels were measured, and immunohistochemistry and real‐time PCR for pro‐inflammatory mediators were also performed. KEY RESULTS The precursor of resolvin D series, 17(R)HDoHE, given systemically, inhibited the development and the maintenance of mechanical hyperalgesia in acute inflammation. Such effects were likely to be associated with modulation of both NF‐κB and COX‐2 in dorsal root ganglia and spinal cord. 17(R)HDoHE was also effective against sub‐chronic pain. Unexpectedly, repeated treatment with 17(R)HDoHE did not modify paw and joint oedema in the sub‐chronic model, while joint stiffness was prevented. Notably, AT‐RvD1 exhibited marked anti‐hyperalgesic effects in acute inflammation when given systemically. The efficacy of long‐term treatment with either 17(R)HDoHE or AT‐RvD1 was partly related to decreased production of TNF‐α and IL‐1β in rat hind paw. CONCLUSIONS AND IMPLICATIONS Our findings provide fresh evidence for the anti‐hyperalgesic properties of 17(R)HDoHE and its pro‐resolution metabolite AT‐RvD1. Such lipid mediators might be useful for treating pain associated with acute or chronic inflammation. LINKED ARTICLE This article is commented on by Xu and Ji, pp. 274–277 of this issue. To view this commentary visit http://dx.doi.org/10.1111/j.1476‐5381.2011.01348.x
Editor: Oxford, UK: Blackwell Publishing Ltd
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

The precursor of resolvin D series and aspirin‐triggered resolvin D1 display anti‐hyperalgesic properties in adjuvant‐induced arthritis in rats

Lima‐Garcia, JF ; Dutra, RC ; da Silva, KABS ; Motta, EM ; Campos, MM ; Calixto, JB

Oxford, UK: Blackwell Publishing Ltd

Buscando em bases de dados remotas. Favor aguardar.